|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US6773707B1
(en)
*
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
*
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6719974B1
(en)
*
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
IL123218A0
(en)
|
1995-08-18 |
1998-09-24 |
Sloan Kettering Inst Cancer |
Heat shock protein-based vaccines and immunotherapies
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
WO1998012208A1
(en)
|
1996-09-20 |
1998-03-26 |
The University Of New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6709672B2
(en)
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
BE1011033A6
(fr)
*
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
ATE327259T1
(de)
*
|
1997-08-05 |
2006-06-15 |
Stressgen Biotechnologies Corp |
Immunantwort gegen hpv antigene hervorgerufen von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einem expressionsvektor fähig zur expression dieser proteine
|
|
IL135860A0
(en)
*
|
1997-10-31 |
2001-05-20 |
Sloan Kettering Inst Cancer |
Conjugate heat shock protein-binding peptides
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
EP1829551B1
(en)
*
|
1998-02-20 |
2010-09-29 |
University of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
US20030236209A1
(en)
*
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
CA2342832A1
(en)
*
|
1998-09-04 |
2000-03-16 |
Powderject Research Limited |
Immunodiagnostics using particle delivery methods
|
|
US20020142974A1
(en)
*
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
|
CA2378097A1
(en)
|
1999-07-08 |
2001-01-18 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
JP2003510334A
(ja)
*
|
1999-09-30 |
2003-03-18 |
コリクサ コーポレイション |
癌及び感染症の予防及び治療のためのストレスタンパク質組成物及び方法
|
|
US8128922B2
(en)
*
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
AU1582801A
(en)
*
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
*
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20010034042A1
(en)
*
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
US7297330B2
(en)
*
|
2000-02-04 |
2007-11-20 |
Thomas Jefferson University |
Low dose haptenized tumor cell and tumor cell extract immunotherapy
|
|
DE10019967A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Fenning Biomed Gmbh Dr |
Antikörper gegen natives gp96, deren Herstellung und Verwendung
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
US7186515B1
(en)
|
2000-06-02 |
2007-03-06 |
University Of Connecticut Health Center |
Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
US7179462B2
(en)
|
2000-06-02 |
2007-02-20 |
University Of Connecticut Health Center |
α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof
|
|
EP1296711B1
(en)
*
|
2000-06-26 |
2006-05-17 |
Stressgen Biotechnologies Corporation |
Hpv-e7 for human papilloma virus treatment
|
|
AU2001278117A1
(en)
*
|
2000-08-03 |
2002-02-18 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CN1107681C
(zh)
*
|
2000-08-11 |
2003-05-07 |
中国科学院微生物研究所 |
乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
|
|
AU2001292674A1
(en)
*
|
2000-09-15 |
2002-04-29 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
*
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US6921534B2
(en)
|
2001-02-05 |
2005-07-26 |
Stressgen Biotechnologies Corporation |
Hepatitis B virus treatment
|
|
CA2447990C
(en)
*
|
2001-05-31 |
2012-01-31 |
Skyepharma Inc. |
Encapsulation of nanosuspensions in liposomes and microspheres
|
|
US7094754B2
(en)
|
2001-08-16 |
2006-08-22 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US6906036B2
(en)
|
2001-08-16 |
2005-06-14 |
Kimberly-Clark Worldwide, Inc. |
Anti-aging and wound healing compounds
|
|
US7071164B2
(en)
|
2001-08-16 |
2006-07-04 |
Kimberly-Clark Worldwide, Inc. |
Anti-cancer and wound healing compounds
|
|
US7186693B2
(en)
|
2001-08-16 |
2007-03-06 |
Kimberly - Clark Worldwide, Inc. |
Metalloproteinase inhibitors for wound healing
|
|
JP4384489B2
(ja)
*
|
2001-08-20 |
2009-12-16 |
ユニバーシティー オブ コネティカット ヘルス センター |
癌及び感染性疾患の治療に有用な熱ショックタンパク質又はα−２−マクログロブリンを含む組成物の調製方法
|
|
US20030211971A1
(en)
*
|
2001-09-17 |
2003-11-13 |
Srivastava Pramod K. |
Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins
|
|
WO2003029419A2
(en)
|
2001-10-01 |
2003-04-10 |
Duke University |
Three dimensional structure of crystalline grp94 binding domain, and its methods of use
|
|
US20030194409A1
(en)
*
|
2002-01-17 |
2003-10-16 |
Rothman James E. |
Conjugate heat shock protein-binding peptides
|
|
CA2477417A1
(en)
*
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
IL164799A0
(en)
|
2002-04-25 |
2005-12-18 |
Univ Connecticut |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
JP2005533015A
(ja)
*
|
2002-05-02 |
2005-11-04 |
ユニバーシティー オブ コネティカット ヘルス センター |
抗体療法の有効性を増強するための熱ショックタンパク質の使用
|
|
ATE474851T1
(de)
*
|
2002-10-02 |
2010-08-15 |
Hoffmann La Roche |
Verfahren zur identifizierung antigener peptide
|
|
CA2501577A1
(en)
*
|
2002-10-07 |
2004-04-22 |
Antigenics, Inc. |
Heat shock protein binding fragments of cd91, and uses thereof
|
|
US20060148064A1
(en)
*
|
2002-10-25 |
2006-07-06 |
Srivastava Pramod K |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
|
WO2005062058A1
(en)
*
|
2002-12-13 |
2005-07-07 |
Aurelium Biopharma Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
CA2509902A1
(en)
|
2002-12-13 |
2004-07-01 |
Aurelium Biopharma Inc. |
Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7670604B2
(en)
|
2002-12-13 |
2010-03-02 |
Aurelium Biopharma, Inc. |
Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7148194B2
(en)
|
2002-12-30 |
2006-12-12 |
Kimberly-Clark Worldwide, Inc. |
Method to increase fibronectin
|
|
DE60323682D1
(de)
*
|
2003-01-03 |
2008-10-30 |
Aurelium Biopharma Inc |
Auf hsc70 gerichtete diagnostika und therapeutika für eine gegen mehrere arzneistoffe resistente tumorerkrankung
|
|
JP2006519784A
(ja)
*
|
2003-01-28 |
2006-08-31 |
シャンハイ、サンウエイ、バイアテク、カムパニ、リミティド |
原発癌および転移癌に対する治療（ａ２）温熱療法と腫瘍溶解の同時治療（ａ３）
|
|
US7420037B2
(en)
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
RU2324493C2
(ru)
*
|
2003-02-20 |
2008-05-20 |
Юниверсити Оф Коннектикут Хелт Сентер |
Способ применения композиций, содержащих белки теплового шока или альфа-2-макроглобулин, для лечения рака и инфекционных болезней
|
|
US7638122B2
(en)
*
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
|
US7358042B2
(en)
*
|
2003-03-14 |
2008-04-15 |
Aurelium Biopharma, Inc. |
Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7309491B2
(en)
*
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
WO2004098526A2
(en)
*
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
US20060029610A1
(en)
*
|
2003-05-12 |
2006-02-09 |
Yair Argon |
GRP94-based compositions and methods of use thereof
|
|
JP2007504840A
(ja)
*
|
2003-05-12 |
2007-03-08 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
Ｇｒｐ９４ベース組成物及びそれらの使用方法
|
|
US7189700B2
(en)
|
2003-06-20 |
2007-03-13 |
Kimberly-Clark Worldwide, Inc. |
Anti-chrondrosarcoma compounds
|
|
JPWO2006025525A1
(ja)
*
|
2004-09-03 |
2008-05-08 |
株式会社医学生物学研究所 |
樹状細胞において抗原提示されやすいタンパク質の選択方法
|
|
US20080194020A1
(en)
*
|
2004-09-03 |
2008-08-14 |
Medical And Biological Laboratories Co., Ltd. |
Methods For Producing Dendritic Cells That Have Acquired Ctl-Inducing Ability
|
|
CA2594040A1
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
US20070167422A1
(en)
*
|
2006-01-18 |
2007-07-19 |
Yu Kwok S |
Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
|
|
US20100330105A1
(en)
*
|
2006-08-22 |
2010-12-30 |
John Hopkins University |
Anticancer Combination Therapies
|
|
JP2010509403A
(ja)
*
|
2006-11-13 |
2010-03-25 |
ファンクショナル・ジェネティクス・インコーポレーテッド |
エスコートタンパク質の治療ターゲティング
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
KR20110009095A
(ko)
|
2008-03-03 |
2011-01-27 |
더 유니버시티 오브 마이애미 |
동종 이계 암 세포-기반 면역 요법
|
|
JP2011515399A
(ja)
|
2008-03-20 |
2011-05-19 |
ユニバーシティー オブ マイアミ |
熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
US7932018B2
(en)
*
|
2008-05-06 |
2011-04-26 |
Az Electronic Materials Usa Corp. |
Antireflective coating composition
|
|
EP3578195B1
(en)
|
2008-06-26 |
2023-08-09 |
Zevra Denmark A/S |
Use of hsp70 as a regulator of enzymatic activity
|
|
GB0816242D0
(en)
*
|
2008-09-05 |
2008-10-15 |
Immunobiology Ltd |
Method of purifying protien complexes
|
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
|
CN102223894A
(zh)
*
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
GB0910591D0
(en)
|
2009-06-19 |
2009-07-29 |
Immunobiology Ltd |
Method for the purification of protein complexes
|
|
RU2013125923A
(ru)
|
2010-11-30 |
2015-01-10 |
Орфазиме Апс |
СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
|
|
FR3005649B1
(fr)
|
2013-05-15 |
2023-03-31 |
Urodelia |
Poudre d'hydroxyapatite et son procede de production, composition a base de cette poudre et son procede de preparation et kit comprenant cette poudre
|
|
RS61678B1
(sr)
|
2014-05-28 |
2021-05-31 |
Agenus Inc |
Anti-gitr antitela i postupci za njihovu primenu
|
|
HUE054957T2
(hu)
|
2014-09-15 |
2021-10-28 |
Orphazyme As |
Arimoklomol készítése
|
|
SG11201705844SA
(en)
|
2015-02-06 |
2017-08-30 |
Heat Biologics Inc |
Vector co-expressing vaccine and costimulatory molecules
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
WO2016196237A1
(en)
|
2015-05-29 |
2016-12-08 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
|
SG10201913276WA
(en)
|
2015-09-01 |
2020-02-27 |
Agenus Inc |
Anti-pd-1 antibodies and methods of use thereof
|
|
IL299072A
(en)
|
2015-12-02 |
2023-02-01 |
Memorial Sloan Kettering Cancer Center |
Antibodies and methods for using them
|
|
WO2017151655A1
(en)
*
|
2016-02-29 |
2017-09-08 |
The Curators Of The University Of Missouri |
Cancer immune-based therapy
|
|
WO2017178029A1
(en)
|
2016-04-13 |
2017-10-19 |
Orphazyme Aps |
Heat shock proteins and cholesterol homeostasis
|
|
HUE052158T2
(hu)
|
2016-04-29 |
2021-04-28 |
Orphazyme As |
Arimoklomol a glükocerebroszidázzal társult rendellenességek kezeléséhez
|
|
KR20230091191A
(ko)
|
2016-05-27 |
2023-06-22 |
아게누스 인코포레이티드 |
항-tim-3 항체 및 이의 사용 방법
|
|
CA3040123A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
MX2019003683A
(es)
|
2016-10-11 |
2019-08-22 |
Agenus Inc |
Anticuerpos anti gen 3 de activación linfocítica (lag 3 ) y métodos para usarlos.
|
|
CN118634323A
(zh)
|
2016-12-07 |
2024-09-13 |
艾吉纳斯公司 |
抗体和其使用方法
|
|
EP4289484A3
(en)
|
2016-12-07 |
2024-03-06 |
Agenus Inc. |
Anti-ctla-4 antibodies and methods of use thereof
|
|
EP3568412A2
(en)
|
2017-01-13 |
2019-11-20 |
Agenus Inc. |
T cell receptors that bind to ny-eso-1 and methods of use thereof
|
|
US11548930B2
(en)
|
2017-04-04 |
2023-01-10 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
MX2019012223A
(es)
|
2017-04-13 |
2019-12-09 |
Agenus Inc |
Anticuerpos anti-cd137 y metodos de uso de los mismos.
|
|
RS64576B1
(sr)
|
2017-05-01 |
2023-10-31 |
Agenus Inc |
Anti-tigit antitela i postupci njihove primene
|
|
CA3073055A1
(en)
|
2017-09-04 |
2019-03-07 |
Agenus Inc. |
T cell receptors that bind to mixed lineage leukemia (mll)-specific phosphopeptides and methods of use thereof
|
|
FR3078887B1
(fr)
|
2018-03-14 |
2020-12-18 |
Urodelia |
Vaccins autologues contre le cancer
|
|
EP3784688A2
(en)
|
2018-04-26 |
2021-03-03 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
KR20220053007A
(ko)
|
2019-08-30 |
2022-04-28 |
아게누스 인코포레이티드 |
항-cd96 항체 및 이의 사용 방법
|
|
WO2022070052A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Alma Bio Therapeutics |
Nucleic acid therapy for differential modulation of host microflora
|
|
IL303026A
(en)
|
2020-11-19 |
2023-07-01 |
Zevra Denmark As |
Processes for preparing arimoclomol citrate and its intermediates
|
